Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy

Andrés Duarte-Rojo, Astrid Ruiz-Margáin, Ricardo U. Macias-Rodriguez, Francisco Javier Cubero, José Estradas-Trujillo, Rosa Ma Muñoz-Fuentes, Aldo Torre*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

AIM: To evaluate the association between serum concentrations of S100β in patients with cirrhosis and the presence of low grade hepatic encephalopathy (HE). METHODS: This was a cross-sectional study. The population was categorized into four groups healthy subjects, cirrhosis without HE, cirrhosis with covert hepatic encephalopathy (CHE) and cirrhosis with overt HE. Kruskal-Wallis, Mann Whitney's U with Bonferroni adjustment Spearman correlations and area under the ROC were used as appropriate. RESULTS: A total of 61 subjects were included, 46 cirrhotic patients and 15 healthy volunteers. S100β values were different among all groups, and differences remained significant between groups 1 and 2 (P < 0.001), and also between groups 2 and 3 (P = 0.016), but not between groups 3 and 4. In cirrhotic patients with HE S100β was higher than in patients without HE [0.18 (0.14-0.28) ng/mL vs 0.11 (0.06-0.14) ng/mL, P < 0.001]. There was a close correlation between serum concentrations of S100β and psychometric hepatic encephalopathy score in patients with cirrhosis without HE compared to the patients with cirrhosis with CHE (r = -0.413, P = 0.019). ROC curve analysis yielded > 0.13 ng/mL as the best cutoff value of S100β for the diagnosis of HE (sensitivity 83.3%, specificity 63.6%). CONCLUSION: Serum concentrations of S100β are higher in patients with cirrhosis than in healthy volunteers, and are further increased in the presence of hepatic encephalopathy. The results suggest that serum biomarkers such as S100β could help in the correct characterization of incipient stages of HE.

Original languageEnglish (US)
Pages (from-to)4397-4402
Number of pages6
JournalWorld Journal of Gastroenterology
Volume22
Issue number17
DOIs
StatePublished - May 7 2016

Keywords

  • Astrocyte
  • Critical flicker frequency
  • Hepatic encephalopathy
  • Psychometric hepatic encephalopathy score
  • S100β protein

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint

Dive into the research topics of 'Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy'. Together they form a unique fingerprint.

Cite this